EMA/PE/0000232890 - paediatric investigation plan

clevidipine

Key facts

• Invented name:
  Cleviprex and associated names
• Active substance:
  clevidipine
• Therapeutic area:
  Vascular disorders
• Decision number:
  P/0009/2014
• PIP number:
  EMA/PE/0000232890
• Pharmaceutical form(s):
  Emulsion for injection
• Condition(s) / indication(s):
  Treatment of hypertensive disease
• Route(s) of administration:
  Intravenous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  21/03/2025
• Compliance check done:
  Не

Decision

EMA/PE/0000232890: EMA decision of 21 March 2025 on the acceptance of a modification of an agreed paediatric investigation plan for clevidipine (Cleviprex and associated names)

Adopted Reference Number: EMADOC-1700519818-1976294